News

After a global genetic comparison, scientists have discovered that Asia has at least ten ancestral lineages, whereas northern Europe has a single ancestral lineage.

The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.

The reward pathway of the brain causes feelings of happiness but is also involved in behavioral disorders like schizophrenia and addiction. A breakthrough study by scientists in Japan has now identified the role of a protein called Npas4 in the reward pathway, mediated by the well-known proteins MAPK and CBP, opening doors to potential therapies for associated disorders.

Using RNA sequencing techniques, researchers have discovered that an experimental cancer drug could be used to treat a disabling parasitic disease.

Cell-free engineering has evolved from a specialized research tool to the backbone of a variety of applications in synthetic biology that stand to dramatically impact society, from the environment to medicine to education.

A study has identified a genetic network involved in the unique evolutionary trajectory of the modern human face and prosociality not found in Neanderthals.

Scientists have developed an online atlas of gene expressions at single-cell level in Alzheimer’s disease brains, aiming to boost to efforts to identify gene targets for drug development.

Scientists have discovered how stem cell mutations quietly arise and spread throughout a widening field of the colon until they eventually transform into a malignancy.

Recently, Urania Therapeutics announced that it has successfully raised €3.53M ($3.89M) in seed funding to unlock the therapeutic potential of ribosome-based treatments. We spoke with Jean-Paul Renaud, President and CSO of Urania Therapeutics, to learn more about the mechanisms of readthrough compounds and how the company hopes to provide treatment solutions for orphan diseases.

Researchers led by a team from the University of Tsukuba identify a protein that suppresses retroviruses in the human genome, allowing the reprogramming of somatic cells to unlock their hidden potential.